Mechanism of pertussis toxin B oligomer-mediated protection against Bordetella pertussis respiratory infection.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMC 313777)

Published in Infect Immun on December 01, 1990

Authors

R D Shahin1, M H Witvliet, C R Manclark

Author Affiliations

1: Laboratory of Pertussis, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892.

Articles cited by this

Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65

A simple chromatographic method for preparation of gamma globulin. Proc Soc Exp Biol Med (1960) 11.02

Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics (1981) 7.58

Induction of a novel morphological response in Chinese hamster ovary cells by pertussis toxin. Infect Immun (1983) 5.03

A role of the B-oligomer moiety of islet-activating protein, pertussis toxin, in development of the biological effects on intact cells. J Biol Chem (1983) 2.65

Monoclonal antibody against pertussis toxin: effect on toxin activity and pertussis infections. Infect Immun (1984) 2.59

Aerosol infection of mice with Bordetella pertussis. Infect Immun (1980) 2.31

The A protomer of islet-activating protein, pertussis toxin, as an active peptide catalyzing ADP-ribosylation of a membrane protein. Arch Biochem Biophys (1983) 2.21

The standardization of an assay for pertussis toxin and antitoxin in microplate culture of Chinese hamster ovary cells. J Biol Stand (1985) 1.79

Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis. J Exp Med (1990) 1.67

Effect of monoclonal antibody to pertussis toxin on toxin activity. Infect Immun (1987) 1.61

Monoclonal antibodies to pertussis toxin: utilization as probes of toxin function. Hybridoma (1989) 1.43

Immune response to the B oligomer of pertussis toxin. Infect Immun (1987) 1.36

Monoclonal antibodies as probes of tetanus toxin structure and function. Infect Immun (1983) 1.34

Adenine nucleotides promote dissociation of pertussis toxin subunits. J Biol Chem (1986) 1.17

Effect of systemic immunization on pulmonary clearance of Haemophilus influenzae type b. Infect Immun (1985) 1.16

The interaction between pertussis toxin and 10 monoclonal antibodies. Acta Pathol Microbiol Immunol Scand C (1987) 1.00

Monoclonal antibody against pertussis toxin: relationship between toxin neutralization and mouse protection activities. Ann Sclavo Collana Monogr (1986) 0.86

Articles by these authors

Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics (1981) 7.58

Extracytoplasmic adenylate cyclase of Bordetella pertussis. Proc Natl Acad Sci U S A (1976) 3.57

Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase. J Biol Chem (1983) 3.31

Separation and purification of the hemagglutinins from Bordetella pertussis. Infect Immun (1983) 2.85

Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis. Infect Immun (1981) 2.77

Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussis. Infect Immun (1988) 2.55

ADP-ribosylation of transducin by pertussis toxin blocks the light-stimulated hydrolysis of GTP and cGMP in retinal photoreceptors. J Biol Chem (1984) 2.39

Aerosol infection of mice with Bordetella pertussis. Infect Immun (1980) 2.31

Phase-shift markers in Bordetella: alterations in envelope proteins. J Infect Dis (1981) 2.23

Filamentous hemagglutinin has a major role in mediating adherence of Bordetella pertussis to human WiDr cells. Infect Immun (1986) 2.18

Protective activities of the filamentous hemagglutinin and the lymphocytosis-promoting factor of Bordetella pertussis in mice. J Infect Dis (1984) 1.96

Sensitivity and specificity of clinical case definitions for pertussis. Am J Public Health (1988) 1.93

Comparison of type 2 and type 6 fimbriae of Bordetella pertussis by using agglutinating monoclonal antibodies. Infect Immun (1988) 1.92

Lectin-like binding of pertussis toxin to a 165-kilodalton Chinese hamster ovary cell glycoprotein. J Biol Chem (1988) 1.88

Intracellular localization of the dermonecrotic toxin of Bordetella pertussis. Infect Immun (1979) 1.83

Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis. Infect Immun (1983) 1.77

Agglutinating monoclonal antibodies that specifically recognize lipooligosaccharide A of Bordetella pertussis. Infect Immun (1988) 1.71

Immunologic response to early and routine DTP immunization in infants. Pediatrics (1984) 1.71

Binding of pertussis toxin to eucaryotic cells and glycoproteins. Infect Immun (1989) 1.71

Pertussis toxin substrate, the putative Ni component of adenylyl cyclases, is an alpha beta heterodimer regulated by guanine nucleotide and magnesium. Proc Natl Acad Sci U S A (1983) 1.67

Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis. J Exp Med (1990) 1.67

Infants and children with convulsions and hypotonic-hyporesponsive episodes following diphtheria-tetanus-pertussis immunization: follow-up evaluation. Pediatrics (1988) 1.66

Ns and Ni, the stimulatory and inhibitory regulatory components of adenylyl cyclases. Purification of the human erythrocyte proteins without the use of activating regulatory ligands. J Biol Chem (1984) 1.62

Stimulation and inhibition of adenylyl cyclases mediated by distinct regulatory proteins. Nature (1983) 1.59

Nonfermentative bacilli associated with man. I. Nomenclature. Am J Clin Pathol (1970) 1.57

Role of the A subunit of pertussis toxin in alteration of Chinese hamster ovary cell morphology. Infect Immun (1987) 1.52

Identification of Bordetella pertussis infection by shared-primer PCR. J Clin Microbiol (1994) 1.49

Purification and characterization of fimbriae isolated from Bordetella pertussis. Infect Immun (1985) 1.47

Monoclonal antibodies to pertussis toxin: utilization as probes of toxin function. Hybridoma (1989) 1.43

A comparison of laboratory and clinical methods for diagnosing pertussis in an outbreak in a facility for the developmentally disabled. J Infect Dis (1988) 1.37

Structural characterization of pertussis toxin A subunit. J Biol Chem (1987) 1.36

Immune response to the B oligomer of pertussis toxin. Infect Immun (1987) 1.36

Epitopes on the S1 subunit of pertussis toxin recognized by monoclonal antibodies. Infect Immun (1989) 1.32

Pertussis encephalopathy with a normal brain biopsy and elevated lymphocytosis-promoting factor antibodies. Pediatr Infect Dis (1984) 1.25

Pertussis toxin inhibition of chemotaxis and the ADP-ribosylation of a membrane protein in a human-mouse hybrid cell line. Proc Natl Acad Sci U S A (1985) 1.24

Adenine nucleotides promote dissociation of pertussis toxin subunits. J Biol Chem (1986) 1.17

Cloning and sequencing of the structural gene for the porin protein of Bordetella pertussis. Mol Microbiol (1991) 1.13

In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor. Infect Immun (1984) 1.12

Biphasic effect of pertussis vaccine on serum insulin in mice. Infect Immun (1983) 1.11

Stimulation of the thiol-dependent ADP-ribosyltransferase and NAD glycohydrolase activities of Bordetella pertussis toxin by adenine nucleotides, phospholipids, and detergents. Biochemistry (1986) 1.10

Phase-shift markers in the genus Bordetella: loss of cytochrome d-629 in phase IV variants. Microbios (1981) 1.10

Purification and characterization of serotype 6 fimbriae from Bordetella pertussis and comparison of their properties with serotype 2 fimbriae. Infect Immun (1987) 1.10

Lymphocytosis-promoting factor of Bordetella pertussis alters mononuclear phagocyte circulation and response to inflammation. Infect Immun (1984) 1.07

Regulation of Bordetella pertussis extracytoplasmic adenylate cyclase. Adv Cyclic Nucleotide Res (1978) 1.06

Pertussis in a previously immunized child with human immunodeficiency virus infection. J Pediatr (1989) 1.05

Human serologic response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis. J Infect Dis (1991) 1.04

Purification of serotype 2 fimbriae of Bordetella pertussis and their identification as a mouse protective antigen. Dev Biol Stand (1985) 1.02

Pertussis vaccine research. Bull World Health Organ (1981) 0.99

Mechanisms in the vectorial receptor-adenylate cyclase signal transduction. Adv Cyclic Nucleotide Protein Phosphorylation Res (1984) 0.98

A protein activator for the adenylate cyclase of Bordetella pertussis. J Biol Chem (1979) 0.98

Adenyl cyclase in Bordetella pertussis vaccines. J Infect Dis (1977) 0.97

Proliferative response of immune mouse T-lymphocytes to the lymphocytosis-promoting factor of Bordetella pertussis. Infect Immun (1984) 0.95

Analyses of adverse reactions to diphtheria and tetanus toxoids and pertussis vaccine by vaccine lot, endotoxin content, pertussis vaccine potency and percentage of mouse weight gain. Pediatr Infect Dis J (1989) 0.94

Evaluation of a ribosomal vaccine against pertussis. Infect Immun (1979) 0.93

Evidence for a high attack rate and efficacy of erythromycin prophylaxis in a pertussis outbreak in a facility for the developmentally disabled. J Infect Dis (1988) 0.92

Selective breeding to establish a standard mouse for pertussis vaccine bioassay. II. Bioresponses of mice susceptible and resistant to sensitization by pertussis vaccine HSF. J Biol Stand (1975) 0.92

Immune response to dimeric subunits of the pertussis toxin B oligomer. Infect Immun (1989) 0.89

The pattern of the immune response in vibriosis. J Pathol Bacteriol (1965) 0.88

The current status of pertussis vaccine: an overview. Adv Appl Microbiol (1976) 0.88

Antibodies to Bordetella pertussis in human colostrum and their protective activity against aerosol infection of mice. Infect Immun (1985) 0.87

Role of cysteine 41 of the A subunit of pertussis toxin. J Biol Chem (1989) 0.87

Characterization of the filamentous hemagglutinin from Bordetella pertussis by gel electrophoresis. Mol Cell Biochem (1986) 0.87

Spurious protein activators of Bordetella pertussis adenylate cyclase. Eur J Biochem (1981) 0.86

Assay of pertussis vaccine toxicity by a rat-paw-oedema method. J Med Microbiol (1977) 0.83

Comparison of meningococcal outer membrane protein vaccines solubilized with detergent or C polysaccharide. Antonie Van Leeuwenhoek (1987) 0.83

Involvement of filamentous hemagglutinin in the adherence of Bordetella pertussis to human WiDr cell cultures. Dev Biol Stand (1985) 0.82

Effects of exogenous agents on the action of Bordetella parapertussis heat-labile toxin on guinea pig skin. Infect Immun (1990) 0.82

Binding of ATP by pertussis toxin and isolated toxin subunits. Biochemistry (1990) 0.82

O-polysaccharide-protein conjugates induce high levels of specific antibodies to Pseudomonas aeruginosa immunotype 3 lipopolysaccharide. Vaccine (1987) 0.82

Structural and functional properties of a 69-kilodalton outer membrane protein of Bordetella pertussis. Tokai J Exp Clin Med (1988) 0.81

Prospects for a new acellular pertussis vaccine. Ann Inst Pasteur Microbiol (1986) 0.81

Efficacy of combined porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae vaccination in piglets. Vet Rec (2010) 0.79

Determination of T cell epitopes on the S1 subunit of pertussis toxin. J Immunol (1990) 0.79

Biochemical properties of pertussis toxin. Tokai J Exp Clin Med (1988) 0.78

Bordetella pertussis does not induce beta-adrenergic blockade. Infect Immun (1978) 0.78

Purification and analysis of the antigenicity of a 69,000 Da protein from Bordetella pertussis. FEMS Microbiol Lett (1990) 0.77

DTP vaccine reactions: effect of prior reactions on rate of subsequent reactions. Dev Biol Stand (1985) 0.77

Outbreaks of pertussis in the United States: the Wisconsin experience. Tokai J Exp Clin Med (1988) 0.76

Altered mononuclear phagocyte function in mice treated with the lymphocytosis promoting factor of Bordetella pertussis. Dev Biol Stand (1985) 0.76

[Research on whooping cough vaccine]. Bull World Health Organ (1981) 0.75

Inhibition of heat-labile toxin from Bordetella parapertussis by fatty acids. Infect Immun (1990) 0.75

Development of a cell culture assay for Bordetella parapertussis heat-labile toxin. Biologicals (1990) 0.75

From the National Institutes of Health: summary of an International Symposium on Pertussis. J Infect Dis (1979) 0.75

Repression of adenylate cyclase in the genus Bordetella. Microbios (1982) 0.75

Class 1/3 outer membrane protein vaccine against group B, type 15, subtype 16 meningococci. Dev Biol Stand (1986) 0.75

Recent advances in the development of pertussis vaccines. Biotechnology (1992) 0.75

Simultaneous administration of live attenuated measles vaccine with DTP vaccine. Pediatrics (1978) 0.75